Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the detailed trial information with a generic error screen. This blocks access to the trial’s details, contacts, locations, and documents until the issue is resolved.SummaryDifference18%

- Check19 days agoChange DetectedA site-wide revision badge was added (v3.7.0). Melanoma-related glossary entries (Melanoma, related topics:, MedlinePlus Genetics) and an earlier revision note (Revision: v3.6.6) were removed.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page's related topics metadata was updated to include Melanoma and MedlinePlus Genetics. The revision version was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check40 days agoChange DetectedRemoved Melanoma, the related topics header, and MedlinePlus Genetics from the page's related topics section. This reduces the visible topical references that help categorize and surface the study.SummaryDifference0.2%

- Check47 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics to the related topics section, providing quick access to background resources related to the study.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision metadata was updated from v3.6.4 to v3.6.5, indicating a new page release rather than a substantive content change.SummaryDifference0.1%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.